Efforts Are Underway to Refine Prognostic Value of ctDNA to Guide Adjuvant Therapy in CRC
Circulating tumor DNA status at the time of postoperative minimal residual disease is a prognostic factor of recurrence for patients with radically resected stage II to IV colorectal cancer
United States Jun Watanabe National Cancer Institute Colon American Society Of Clinical Oncology Breakthrough Department Of Surgery Anal Task
Source: onclive.com